Publication: 4864

Publication: 4864

Alliance A072301: A Phase III trial of radiotherapy followed by adjuvant temozolomide in combination with vorasidenib vs placebo in IDH-mutated newly diagnosed grade 3 astrocytoma (VORTEX).

DOI

Google Scholar

Citation:

Meeting Instance:: ASCO 2026
Year:: 2026
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:: Servier
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Ugonma N. Chukwueke Rifaquat Rahman Susan Geyer Rachael Vaubel Ashlee Loughan Caterina Giannini Timothy Kaufmann Benjamin M. Ellingson Sani H. Kizilbash Amylou Dueck Claire Yee Christine Lu-Emerson Julie J. Miller Daniel Trifiletti Jeffrey Wefel Priya Kumthekar Evanthia Galanis Patrick Wen

Networks:: CA006, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-TX035, MAINE, VCU

Study: Alliance-A072301
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: